Mercy Catholic Medical Center
Darby, Pennsylvania, 19023, United States
NCT Number: NCT01501123
PREHOSPITAL AGITATION AND SEDATION TRIAL (PHAST)
* The goal of the PHAST is to demine whether haloperidol is superior to midazolam for the sedation of agitated patients in the prehospital environment * The primary outcome is the time to a Richmond Agitation and Sedation Scale (RASS) ≤1
o The RASS is a well validated standardized score to measure a patient's agitation * The secondary outcomes are
* Time until RASS returns to 0 or 1 if RASS <0 * Need for additional sedation * Adverse effects (need for intubation, arrhythmia) * Mercy EMS will be the only EMS agency in the Commonwealth of Pennsylvania carrying haloperidol * Identification of potential study patients will be per state protocols * Exclusion Criteria for the study * Age <18 * Pregnant * Allergic to study medication * Transport to hospital other than Mercy Fitzgerald Hospital * Unable to reach medical command prior to giving medication * When a paramedic identifies a possible study candidate, the paramedic will consult medical command to see if the patient is appropriate for the study * If the medical command agrees the patient is appropriate for the study, patients will be randomized to * Odd days: Haloperidol 5mg IM (age <65) or haloperidol 2.5 mg IM (age ≥65) * Even days: Midazolam 0.05 mg IM to maximum of 5mg IM (age <65) or maximum of 2.5mg (age ≥65) * The RASS will be documented by the prehospital providers every 5 minutes until arrival at the hospital * Once the patient arrives at the ED, the RASS will be documented in PICIS® by the emergency department nurse at the time of triage and at a minimum of hourly until the RASS =0 or 1 for 2 consecutive hours * Questions may be directed to Dr. Isenberg at [email protected] or at (267) 205-6453
Richmond Agitation Sedation Scale
RASS RASS Description
* 4 Combative, violent, danger to staff * 3 Pulls or removes tube(s) or catheters; aggressive * 2 Frequent non-purposeful movement * 1 Anxious, apprehensive, but not aggressive 0 Alert and calm
* 1 Awakens to voice (eye opening/contact) >10 sec * 2 Light sedation, briefly awakens to voice (eye opening/contact) <10 sec * 3 Moderate sedation, movement or eye opening. No eye contact * 4 Deep sedation, no response to voice, but movement or eye opening to physical stimulation * 5 Unarousable, no response to voice or physical stimulation
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Darby, Pennsylvania, 19023, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Exclusion criteria
5mg IM
IM midazolam
Time frame: 10 minutes
Catholic Health East
Other
Re-hospital Agitation and Sedation Trial: A Randomized Controlled Trial of Haloperidol Versus Midazolam for the Sedation of the Agitated Patient
Acronym: PHAST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619326
Aberrant Motor Behavior in Dementia, Agitation
Changhua, Taiwan
View Trial DetailsNCT04268303
Aberrant Motor Behavior in Dementia, Agitation
Little Rock, Arkansas, United States
View Trial DetailsNCT03317067
Aberrant Motor Behavior in Dementia, Agitation
Clermont-Ferrand, France
View Trial DetailsNCT05271552
Aberrant Motor Behavior in Dementia, Agitation
Phoenix, Arizona, United States
View Trial Details